گارداسیل (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "گارداسیل" in Persian language version.

refsWebsite

Global rank Persian rank

25nih.gov

4^th place

5^th place

21doi.org

2^nd place

13web.archive.org

1^st place

4europa.eu

68^th place

179^th place

3fda.gov

447^th place

382^nd place

2cancer.gov

1,684^th place

533^rd place

2medscape.com

719^th place

248^th place

2cdc.gov

218^th place

126^th place

1karger.com

4,489^th place

4,099^th place

1handle.net

102^nd place

515^th place

1semanticscholar.org

11^th place

52^nd place

1pezeshk.us

low place

690^th place

1gardasil9.com

low place

1irna.ir

643^rd place

13^th place

1drmahdighazi.com

low place

1worldcat.org

5^th place

12^th place

1ama-assn.org

3,257^th place

1,272^nd place

1webmd.com

1,169^th place

175^th place

1neurologyadvisor.com

low place

1mja.com.au

low place

6,609^th place

1omicsonline.org

low place

1drugs.com

399^th place

104^th place

1rte.ie

491^st place

1,907^th place

1vaccineimpact.com

low place

1trueactivist.com

low place

1discovermagazine.com

3,042^nd place

5,586^th place

ama-assn.org

jama.ama-assn.org

Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J (August 2009). "Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine". JAMA. 302 (7): 750–7. doi:10.1001/jama.2009.1201. PMID 19690307. Archived from the original on 2010-12-02.

cancer.gov

"Human Papillomavirus (HPV) Vaccines". National Cancer Institute. Archived from the original on 21 June 2008. Retrieved 18 April 2020.
«Human Papillomavirus (HPV) Vaccines». National Cancer Institute. مه ۱۶, ۲۰۱۸.

cdc.gov

"FAQs about HPV Safety". Centers for Disease Control and Prevention (به انگلیسی). 19 December 2018. verall, 97% were non-serious reports; 3% of reports have been classified as serious.
«Human Papillomavirus (HPV) Vaccine Safety». Centers for Disease Control and Prevention. ژانویه ۳۰, ۲۰۱۸.

discovermagazine.com

blogs.discovermagazine.com

"Should Boys Be Given the HPV Vaccine? The Science Is Weaker than the Marketing". Discover magazine The Crux. 14 November 2011. Archived from the original on 7 May 2019. Retrieved 26 April 2019.

doi.org

Gao G, Smith DI (2016). "Human Papillomavirus and the Development of Different Cancers". Cytogenetic and Genome Research. 150 (3–4): 185–193. doi:10.1159/000458166. PMID 28245440. Archived from the original on 17 July 2020. Retrieved 19 April 2020.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Verdenius, Inge. "Cross protection against HPV might prevent type replacement". The Lancet. Infectious Diseases. 13 (3): 195. doi:10.1016/S1473-3099(13)70024-0. ISSN 1474-4457. PMID 23427887.
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J (August 2009). "Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine". JAMA. 302 (7): 750–7. doi:10.1001/jama.2009.1201. PMID 19690307. Archived from the original on 2010-12-02.
Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Salvati, Dionigi; Gentili, Marta; Brusadelli, Tatiana; Pozzi, Marco; Antoniazzi, Stefania; Clementi, Emilio; Radice, Sonia (2014). "On the association between human papillomavirus vaccine and primary ovarian failure". American Journal of Reproductive Immunology (New York, N.Y. : 1989). pp. 293–294. doi:10.1111/aji.12190.
Wiznitzer, Max (2014). "RE: Human papillomavirus vaccine and primary ovarian failure paper". American Journal of Reproductive Immunology (New York, N.Y. : 1989). p. 259. doi:10.1111/aji.12283.
Katoulis, A. C.; Liakou, A.; Bozi, E.; Theodorakis, M.; Alevizou, A.; Zafeiraki, A.; Mistidou, M.; Stavrianeas, N. G. (2010). "Erythema multiforme following vaccination for human papillomavirus". Dermatology (Basel, Switzerland). pp. 60–62. doi:10.1159/000254898.
Cervantes, Jorge L; Doan, Amy Hoanganh (28 May 2018). "Discrepancies in the evaluation of the safety of the human papillomavirus vaccine". Memórias do Instituto Oswaldo Cruz. doi:10.1590/0074-02760180063.
Pugnet, Gregory; Ysebaert, Loïc; Bagheri, Haleh; Montastruc, Jean-Louis; Laurent, Guy (8 June 2009). "Immune thrombocytopenic purpura following human papillomavirus vaccination". Vaccine. p. 3690. doi:10.1016/j.vaccine.2009.04.004.
Fernández-Fournier, Mireya; Díaz de Terán, Javier; Barranco, Antonio Tallón; Puertas, Inmaculada (11 September 2014). "Early cervical myelitis after human papilloma virus vaccination". Neurology® Neuroimmunology & Neuroinflammation. doi:10.1212/NXI.0000000000000031.
Yonee, Chihiro; Toyoshima, Mitsuo; Maegaki, Yoshihiro; Kodama, Yuichi; Hayami, Hiroshi; Takahashi, Yukitoshi; Kusunoki, Susumu; Uchibori, Ayumi; Chiba, Atsuro; Kawano, Yoshifumi (October 2013). "Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report". Neuropediatrics. pp. 265–267. doi:10.1055/s-0033-1333873.
Souayah, Nizar; Michas-Martin, P. A.; Nasar, Abu; Krivitskaya, Nataliya; Yacoub, Hussam A.; Khan, Hafiz; Qureshi, Adnan I. (29 January 2011). "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009". Vaccine. pp. 886–889. doi:10.1016/j.vaccine.2010.09.020.
Soldevilla, H. F.; Briones, S. F. R.; Navarra, S. V. (2012). "Systemic lupus erythematosus following HPV immunization or infection?". Lupus. pp. 158–161. doi:10.1177/0961203311429556.
Sutton, I.; Lahoria, R.; Tan, Il; Clouston, P.; Barnett, Mh (2008). "CNS demyelination and quadrivalent HPV vaccination". Multiple Sclerosis (Houndmills, Basingstoke, England). pp. 116–119. doi:10.1177/1352458508096868.
DiMario, Francis J.; Hajjar, Mirna; Ciesielski, Thomas (2010). "A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus". Journal of Child Neurology. pp. 321–327. doi:10.1177/0883073809349322.
Miranda, Sara; Chaignot, Christophe; Collin, Cédric; Dray-Spira, Rosemary; Weill, Alain; Zureik, Mahmoud (2017). "Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France". Vaccine. pp. 4761–4768. doi:10.1016/j.vaccine.2017.06.030.
Merrett, Neil D.; Biankin, Andrew V.; Chang, David; Das, Amitabha (4 August 2008). "Pancreatitis following human papillomavirus vaccination". The Medical Journal of Australia (به انگلیسی). p. 178. doi:10.5694/j.1326-5377.2008.tb01960.x.
Bizjak, Mojca; Bruck, Or; Praprotnik, Sonja; Dahan, Shani; Shoenfeld, Yehuda. "Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry". Immunologic Research. pp. 164–167. doi:10.1007/s12026-016-8823-9.
Della Corte, Claudia; Carlucci, Antonio; Francalanci, Paola; Alisi, Anna; Nobili, Valerio (24 June 2011). "Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl". Vaccine. pp. 4654–4656. doi:10.1016/j.vaccine.2011.05.002.
Brotherton, Julia M.L.; Gold, Mike S.; Kemp, Andrew S.; McIntyre, Peter B.; Burgess, Margaret A.; Campbell-Lloyd, Sue (9 September 2008). "Anaphylaxis following quadrivalent human papillomavirus vaccination". CMAJ: Canadian Medical Association Journal. pp. 525–533. doi:10.1503/cmaj.080916.
Tomljenovic, Lucija (2016). "Death after Quadrivalent Human Papillomavirus (HPV) Vaccination:Causal or Coincidental?". Pharmaceutical Regulatory Affairs: Open Access (به انگلیسی). doi:10.4172/2167-7689.S12-001.

drmahdighazi.com

HPV (2022-01-26). "واکسن گارداسیل" (به انگلیسی).

drugs.com

"Human papillomavirus vaccine Use During Pregnancy". Drugs.com. 11 February 2019. Archived from the original on 5 April 2020. Retrieved 3 April 2020.

europa.eu

ema.europa.eu

"Silgard EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil 9 EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Gardasil EPAR". European Medicines Agency. 17 September 2018. Archived from the original on 11 June 2022. Retrieved 6 July 2022.

emea.europa.eu

"Silgard European Public Assessment Report". European Medicines Agency. 25 September 2009. Archived from the original on 25 December 2008. Retrieved 5 December 2009.

fda.gov

"FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers" (Press release). U.S. Food and Drug Administration (FDA). 2008-09-12. Retrieved 2009-11-11.
"Gardasil package insert" (PDF). Food and Drug Administration.
"Approved Products - Cervarix". US Food & Drug Administration (به انگلیسی). Center for Biologics Evaluation and.

gardasil9.com

"Schedules for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)". Gardasil9.

handle.net

hdl.handle.net

"Human papillomavirus vaccines: WHO position paper, May 2017". Weekly Epidemiological Record. 92 (19): 241–268. May 2017. hdl:10665/255353. PMID 28530369.

irna.ir

932 (۲۰۲۴-۱۱-۰۶). «اطلاعات مردم درباره «پاپیلوما» اندک است/واکسن ۴ ظرفیتی ایرانی در مرحله آزمایش بالینی». ایرنا. دریافت‌شده در ۲۰۲۵-۰۱-۱۴.

karger.com

Gao G, Smith DI (2016). "Human Papillomavirus and the Development of Different Cancers". Cytogenetic and Genome Research. 150 (3–4): 185–193. doi:10.1159/000458166. PMID 28245440. Archived from the original on 17 July 2020. Retrieved 19 April 2020.

medscape.com

Waknine Y (2 October 2006). "International Approvals: Singulair and Gardasil/Silgard". Medscape Today. Archived from the original on 20 May 2013. Retrieved 18 December 2008.
Chustecka Z. (August 18, 2009). "HPV Vaccine: Debate Over Benefits, Marketing, and New Adverse Event Data". Medscape Today. Archived from the original on November 14, 2010. Retrieved 2009-08-27.

mja.com.au

Merrett, Neil D.; Biankin, Andrew V.; Chang, David; Das, Amitabha (4 August 2008). "Pancreatitis following human papillomavirus vaccination". The Medical Journal of Australia (به انگلیسی). p. 178. doi:10.5694/j.1326-5377.2008.tb01960.x.

neurologyadvisor.com

"Multiple Sclerosis Development in Two Teens After HPV Vaccination". Neurology Advisor. 2 February 2018.

nih.gov

ncbi.nlm.nih.gov

Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Salvati, Dionigi; Gentili, Marta; Brusadelli, Tatiana; Pozzi, Marco; Antoniazzi, Stefania; Clementi, Emilio; Radice, Sonia (2014). "On the association between human papillomavirus vaccine and primary ovarian failure". American Journal of Reproductive Immunology (New York, N.Y. : 1989). pp. 293–294. doi:10.1111/aji.12190.
Wiznitzer, Max (2014). "RE: Human papillomavirus vaccine and primary ovarian failure paper". American Journal of Reproductive Immunology (New York, N.Y. : 1989). p. 259. doi:10.1111/aji.12283.
Katoulis, A. C.; Liakou, A.; Bozi, E.; Theodorakis, M.; Alevizou, A.; Zafeiraki, A.; Mistidou, M.; Stavrianeas, N. G. (2010). "Erythema multiforme following vaccination for human papillomavirus". Dermatology (Basel, Switzerland). pp. 60–62. doi:10.1159/000254898.
Cervantes, Jorge L; Doan, Amy Hoanganh (28 May 2018). "Discrepancies in the evaluation of the safety of the human papillomavirus vaccine". Memórias do Instituto Oswaldo Cruz. doi:10.1590/0074-02760180063.
Pugnet, Gregory; Ysebaert, Loïc; Bagheri, Haleh; Montastruc, Jean-Louis; Laurent, Guy (8 June 2009). "Immune thrombocytopenic purpura following human papillomavirus vaccination". Vaccine. p. 3690. doi:10.1016/j.vaccine.2009.04.004.
Sekiguchi, Kenji; Yasui, Naoko; Kowa, Hisatomo; Kanda, Fumio; Toda, Tatsushi (1 November 2016). "Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus". Internal Medicine. pp. 3181–3184.
Yoneda, Makoto (1 November 2016). "Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines". Internal Medicine. pp. 3077–3078.
Fernández-Fournier, Mireya; Díaz de Terán, Javier; Barranco, Antonio Tallón; Puertas, Inmaculada (11 September 2014). "Early cervical myelitis after human papilloma virus vaccination". Neurology® Neuroimmunology & Neuroinflammation. doi:10.1212/NXI.0000000000000031.
Yonee, Chihiro; Toyoshima, Mitsuo; Maegaki, Yoshihiro; Kodama, Yuichi; Hayami, Hiroshi; Takahashi, Yukitoshi; Kusunoki, Susumu; Uchibori, Ayumi; Chiba, Atsuro; Kawano, Yoshifumi (October 2013). "Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report". Neuropediatrics. pp. 265–267. doi:10.1055/s-0033-1333873.
Souayah, Nizar; Michas-Martin, P. A.; Nasar, Abu; Krivitskaya, Nataliya; Yacoub, Hussam A.; Khan, Hafiz; Qureshi, Adnan I. (29 January 2011). "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009". Vaccine. pp. 886–889. doi:10.1016/j.vaccine.2010.09.020.
Soldevilla, H. F.; Briones, S. F. R.; Navarra, S. V. (2012). "Systemic lupus erythematosus following HPV immunization or infection?". Lupus. pp. 158–161. doi:10.1177/0961203311429556.
Sutton, I.; Lahoria, R.; Tan, Il; Clouston, P.; Barnett, Mh (2008). "CNS demyelination and quadrivalent HPV vaccination". Multiple Sclerosis (Houndmills, Basingstoke, England). pp. 116–119. doi:10.1177/1352458508096868.
DiMario, Francis J.; Hajjar, Mirna; Ciesielski, Thomas (2010). "A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus". Journal of Child Neurology. pp. 321–327. doi:10.1177/0883073809349322.
Miranda, Sara; Chaignot, Christophe; Collin, Cédric; Dray-Spira, Rosemary; Weill, Alain; Zureik, Mahmoud (2017). "Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France". Vaccine. pp. 4761–4768. doi:10.1016/j.vaccine.2017.06.030.
Bizjak, Mojca; Bruck, Or; Praprotnik, Sonja; Dahan, Shani; Shoenfeld, Yehuda. "Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry". Immunologic Research. pp. 164–167. doi:10.1007/s12026-016-8823-9.
Della Corte, Claudia; Carlucci, Antonio; Francalanci, Paola; Alisi, Anna; Nobili, Valerio (24 June 2011). "Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl". Vaccine. pp. 4654–4656. doi:10.1016/j.vaccine.2011.05.002.
Brotherton, Julia M.L.; Gold, Mike S.; Kemp, Andrew S.; McIntyre, Peter B.; Burgess, Margaret A.; Campbell-Lloyd, Sue (9 September 2008). "Anaphylaxis following quadrivalent human papillomavirus vaccination". CMAJ: Canadian Medical Association Journal. pp. 525–533. doi:10.1503/cmaj.080916.

pubmed.ncbi.nlm.nih.gov

Gao G, Smith DI (2016). "Human Papillomavirus and the Development of Different Cancers". Cytogenetic and Genome Research. 150 (3–4): 185–193. doi:10.1159/000458166. PMID 28245440. Archived from the original on 17 July 2020. Retrieved 19 April 2020.
"Human papillomavirus vaccines: WHO position paper, May 2017". Weekly Epidemiological Record. 92 (19): 241–268. May 2017. hdl:10665/255353. PMID 28530369.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Verdenius, Inge. "Cross protection against HPV might prevent type replacement". The Lancet. Infectious Diseases. 13 (3): 195. doi:10.1016/S1473-3099(13)70024-0. ISSN 1474-4457. PMID 23427887.
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J (August 2009). "Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine". JAMA. 302 (7): 750–7. doi:10.1001/jama.2009.1201. PMID 19690307. Archived from the original on 2010-12-02.

dailymed.nlm.nih.gov

"Gardasil- human papillomavirus quadrivalent- types 6, 11, 16, and 18 vaccine, recombinant injection, suspension". DailyMed. 2 December 2020. Retrieved 31 March 2022.
"human papillomavirus 9-valent vaccine, recombinant injection, suspension". DailyMed. 20 August 2021.

omicsonline.org

Tomljenovic, Lucija (2016). "Death after Quadrivalent Human Papillomavirus (HPV) Vaccination:Causal or Coincidental?". Pharmaceutical Regulatory Affairs: Open Access (به انگلیسی). doi:10.4172/2167-7689.S12-001.

pezeshk.us

«نسخه آرشیو شده». بایگانی‌شده از اصلی در ۱۲ دسامبر ۲۰۱۳. دریافت‌شده در ۴ فوریه ۲۰۱۴.

rte.ie

Lehane, Mícheál (9 July 2018). "Protest over HPV vaccine takes place at Leinster House". RTE (به انگلیسی).

semanticscholar.org

api.semanticscholar.org

Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.

trueactivist.com

"Robert F Kennedy Jr. Says 70% Of News Advertising Revenue Comes From Big Pharma". True Activist. 1 June 2015.

vaccineimpact.com

"Parents of HPV Vaccine Victims Protest in the Streets of Colombia". Vaccine Impact. H. P. V. vaccine. 13 April 2015.

web.archive.org

Gao G, Smith DI (2016). "Human Papillomavirus and the Development of Different Cancers". Cytogenetic and Genome Research. 150 (3–4): 185–193. doi:10.1159/000458166. PMID 28245440. Archived from the original on 17 July 2020. Retrieved 19 April 2020.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
"Human Papillomavirus (HPV) Vaccines". National Cancer Institute. Archived from the original on 21 June 2008. Retrieved 18 April 2020.
"Silgard European Public Assessment Report". European Medicines Agency. 25 September 2009. Archived from the original on 25 December 2008. Retrieved 5 December 2009.
"Silgard EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil 9 EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Gardasil EPAR". European Medicines Agency. 17 September 2018. Archived from the original on 11 June 2022. Retrieved 6 July 2022.
Waknine Y (2 October 2006). "International Approvals: Singulair and Gardasil/Silgard". Medscape Today. Archived from the original on 20 May 2013. Retrieved 18 December 2008.
«نسخه آرشیو شده». بایگانی‌شده از اصلی در ۱۲ دسامبر ۲۰۱۳. دریافت‌شده در ۴ فوریه ۲۰۱۴.
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J (August 2009). "Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine". JAMA. 302 (7): 750–7. doi:10.1001/jama.2009.1201. PMID 19690307. Archived from the original on 2010-12-02.
Chustecka Z. (August 18, 2009). "HPV Vaccine: Debate Over Benefits, Marketing, and New Adverse Event Data". Medscape Today. Archived from the original on November 14, 2010. Retrieved 2009-08-27.
"Human papillomavirus vaccine Use During Pregnancy". Drugs.com. 11 February 2019. Archived from the original on 5 April 2020. Retrieved 3 April 2020.
"Should Boys Be Given the HPV Vaccine? The Science Is Weaker than the Marketing". Discover magazine The Crux. 14 November 2011. Archived from the original on 7 May 2019. Retrieved 26 April 2019.

webmd.com

Laino, Charlene. "2 ALS Cases May Be Linked to Gardasil Vaccine". WebMD (به انگلیسی).

worldcat.org

Verdenius, Inge. "Cross protection against HPV might prevent type replacement". The Lancet. Infectious Diseases. 13 (3): 195. doi:10.1016/S1473-3099(13)70024-0. ISSN 1474-4457. PMID 23427887.